Deep Track Capital’s NovoCure NVCR Stock Holding History

Deep Track Capital’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,500,000	Closed	-$40.4M	–	74
2023 Q3	$40.4M	Buy	+2,500,000	New	+$72.1M	1.56%	22
2022 Q4	–	Sell	-1,293,761	Closed	-$98.3M	–	69
2022 Q3	$98.3M	Sell	1,293,761 -47,539	-4%	-$3.71M	4.5%	5
2022 Q2	$93.2M	Buy	1,341,300 +341,300	+34%	+$25.7M	6.13%	2
2022 Q1	$82.8M	Buy	1,000,000 +450,000	+82%	+$33.1M	5.31%	1
2021 Q4	$41.3M	Buy	+550,000	New	+$55.2M	2.92%	12

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Deep Track Capital's NVCR Position: Q4 2023 in Review

Deep Track Capital sold out of NovoCure (NVCR) in Q4 2023, closing a stake of 2,500,000 shares — an estimated $40.4M sold.

Deep Track Capital first reported a position in NVCR in Q4 2021 and held it in 5 quarters. The position peaked at $98.3M in Q3 2022. 220 funds tracked by Wall St. Rank hold NVCR as of Q4 2023.

Deep Track Capital reported no remaining NovoCure position as of Q4 2023 after selling out during the quarter.
Deep Track Capital sold 2,500,000 NovoCure shares in Q4 2023, an estimated $40.4M.
Deep Track Capital first reported a position in NovoCure in Q4 2021 and held it in 5 quarters.
Deep Track Capital's NovoCure position peaked at $98.3M in Q3 2022.
220 funds tracked by Wall St. Rank held NovoCure as of Q4 2023.

Based on Deep Track Capital's 13F filing for Q4 2023, filed 14 Feb 2024.